Design and crystal structures of protein kinase B-selective inhibitors in complex with protein kinase a and mutants

被引:56
作者
Breitenlechner, CB
Friebe, WG
Brunet, E
Guido, W
Graul, M
Thomas, U
Künkele, KP
Schäfer, W
Gassel, M
Bosseineyer, D
Huber, R
Engh, RA
Masjost, B [1 ]
机构
[1] Roche Diagnost GmbH, Dept Med Chem, D-82372 Penzberg, Germany
[2] Max Planck Inst Biochem, Abt Strukturforschung, D-82152 Martinsried, Germany
[3] German Canc Res Ctr, Dept Pathochem, D-69120 Heidelberg, Germany
关键词
D O I
10.1021/jm049701n
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Protein kinase B (PKB)-selective inhibitors were designed.. synthesized, and cocrystallized using the AGC kinase family protein kinase A (PKA, often called cAMP-dependent protein kinase),PKA has been used as a surrogate for other members of this family and indeed for protein kinases in general. The high homology between PKA and PKB includes very Similar ATP binding sites and hence similar binding pockets for inhibitors, with only few amino acids that differ between the two kinases. A series of these sites were mutated in PKA in order to improve the surrogate model for a design of PKB-selective inhibitors. Namely, the PKA to PKB exchanges F187L and Q84E enable the design of the selective inhibitors described herein which mimic ATP but extend further into a site not occupied by ATP. In this pocket, selectivity over PKA can be achieved by the introduction of bulkier substituents. Analysis of the cocrystal structures. and binding studies were performed to rationalize the selectivity and improve the design.
引用
收藏
页码:163 / 170
页数:8
相关论文
共 42 条
[1]   Balanol analogues probe specificity determinants and the conformational malleability of the cyclic 3′,5′-adenosine monophosphate-dependent protein kinase catalytic subunit [J].
Akamine, P ;
Madhusudan ;
Brunton, LL ;
Ou, HD ;
Canaves, JM ;
Xuong, NH ;
Taylor, SS .
BIOCHEMISTRY, 2004, 43 (01) :85-96
[2]   PIPERIDINES AND AZABICYCLO COMPOUNDS .1. VIA MICHAEL CONDENSATIONS [J].
ALBERTSON, NF .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1950, 72 (06) :2594-2599
[3]   Mechanism of activation and function of protein kinase B [J].
Alessi, DR ;
Cohen, P .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1998, 8 (01) :55-62
[4]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[5]  
BARBIER P, 1995, Patent No. 663393
[6]  
Barbier P., 1997, WO, Patent No. [9702249, 9702249 AI]
[7]   A multireceptorial binding reinvestigation on an extended class of σ ligands:: N-[ω-(Indan-1-yl and tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine reveal high affinities towards σ1 and EBP sites [J].
Berardi, F ;
Ferorelli, S ;
Colabufo, NA ;
Leopoldo, M ;
Perrone, R ;
Tortorella, V .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (05) :1325-1335
[8]   Oncogenic kinase signalling [J].
Blume-Jensen, P ;
Hunter, T .
NATURE, 2001, 411 (6835) :355-365
[9]   Protein kinase a in complex with rho-kinase inhibitors Y-27632, fasudil, and H-1152P: Structural basis of selectivity [J].
Breitenlechner, C ;
Gassel, M ;
Hidaka, H ;
Kinzel, V ;
Huber, R ;
Engh, RA ;
Bossemeyer, D .
STRUCTURE, 2003, 11 (12) :1595-1607
[10]   The typically disordered n-terminus of PKA can fold as a helix and project the myristoylation site into solution [J].
Breitenlechner, C ;
Engh, RA ;
Huber, R ;
Kinzel, V ;
Bossemeyer, D ;
Gassel, M .
BIOCHEMISTRY, 2004, 43 (24) :7743-7749